Prevalence & prognostic importance of micro-& macro-albuminuria in heart failure- an analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme
Publication
, Journal Article
Jackson, CE; Solomon, SD; Gerstein, HC; Andersson, S; Michelson, EL; Granger, CB; Swedberg, K; Pfeffer, MA; Yusuf, S; Mcmurray, JJV
Published in: EUROPEAN HEART JOURNAL
September 1, 2009
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
September 1, 2009
Volume
30
Start / End Page
876 / 876
Publisher
OXFORD UNIV PRESS
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Jackson, C. E., Solomon, S. D., Gerstein, H. C., Andersson, S., Michelson, E. L., Granger, C. B., … Mcmurray, J. J. V. (2009). Prevalence & prognostic importance of micro-& macro-albuminuria in heart failure- an analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme. EUROPEAN HEART JOURNAL, 30, 876–876.
Jackson, C. E., S. D. Solomon, H. C. Gerstein, S. Andersson, E. L. Michelson, C. B. Granger, K. Swedberg, M. A. Pfeffer, S. Yusuf, and J. J. V. Mcmurray. “Prevalence & prognostic importance of micro-& macro-albuminuria in heart failure- an analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme.” EUROPEAN HEART JOURNAL 30 (September 1, 2009): 876–876.
Jackson CE, Solomon SD, Gerstein HC, Andersson S, Michelson EL, Granger CB, et al. Prevalence & prognostic importance of micro-& macro-albuminuria in heart failure- an analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme. EUROPEAN HEART JOURNAL. 2009 Sep 1;30:876–876.
Jackson, C. E., et al. “Prevalence & prognostic importance of micro-& macro-albuminuria in heart failure- an analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme.” EUROPEAN HEART JOURNAL, vol. 30, OXFORD UNIV PRESS, Sept. 2009, pp. 876–876.
Jackson CE, Solomon SD, Gerstein HC, Andersson S, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, Mcmurray JJV. Prevalence & prognostic importance of micro-& macro-albuminuria in heart failure- an analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2009 Sep 1;30:876–876.
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
September 1, 2009
Volume
30
Start / End Page
876 / 876
Publisher
OXFORD UNIV PRESS
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology